Publications by authors named "Michaela Frey"

Claim this Profile
P
Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
Eva Distler, Jana Albrecht, Ariane Brunk, Shamsul Khan, Elke Schnürer, Michaela Frey

Int J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
Eva Distler, Andrea Bloetz, Jana Albrecht, Saliha Asdufan, Alexander Hohberger, Michaela Frey

Haematologica· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype.
Jana Albrecht, Michaela Frey, Daniel Teschner, Alexander Carbol, Matthias Theobald

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of microencapsulation techniques for the water-soluble drugs nitenpyram and clomipramine HCl.
Susanne Wieland-Berghausen, Uwe Schote, Michaela Frey, Friederike Schmidt

J Control Release· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis